Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
4 hedge funds and large institutions have $8K invested in Acer Therapeutics Inc in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 9 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
69% less funds holding
Funds holding: 13 → 4 (-9)
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
95% less capital invested
Capital invested by funds: $172K → $8K (-$164K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$291 |
| 2 |
Citigroup
New York
|
+$29 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$54K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
-$43K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$23K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$19K |
| 5 |
Bank of New York Mellon
New York
|
-$13K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $7K | +$291 | +30 | +9% |
|
2
Morgan Stanley
New York
| $1K | -$1.13K | -116 | -75% |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| – | -$54K | -7,915 | Closed |
|
|
4
California Public Employees Retirement System
Sacramento,
California
| – | -$43K | -6,385 | Closed |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| – | -$23K | -3,448 | Closed |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$19K | -2,758 | Closed |
|
|
7
Bank of New York Mellon
New York
| – | -$13K | -1,901 | Closed |
|
8
UBS Group
Zurich,
Switzerland
| – | -$5K | -787 | Closed |
|
9
Creative Planning
Overland Park,
Kansas
| – | -$1K | -210 | Closed |
|
|
10
Citigroup
New York
| – | +$29 | +3 | New |
|
ACER Hedge Fund Activity: Q3 2017 in Review
4 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2017, worth a combined $8K — down 95% from $172K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ACER and 1 opened new positions — a net loss of 8 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was BlackRock, adding an estimated $291. The largest seller was Vanguard Group, exiting entirely with an estimated $54K sold.
- 4 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2017, down from 13 in Q2 2017.
- Funds reported $8K of Acer Therapeutics Inc stock for Q3 2017, down 95% quarter-over-quarter.
- 1 fund opened new Acer Therapeutics Inc positions in Q3 2017 and 9 closed out, a net change of -8 holders.
- The largest Acer Therapeutics Inc buyer in Q3 2017 was BlackRock, an estimated $291 added.
- The largest Acer Therapeutics Inc seller in Q3 2017 was Vanguard Group, an estimated $54K sold.
Based on aggregated 13F filings for Q3 2017.